TABLE 2.

Baseline characteristics between those who progressed from MCI and those who did not

	Median (interquartile range) or number (%)
Demographic and clinical characteristics	Not converted to dementia in 1 year (n = 204)	Converted to dementia in 1 year (n = 46)	P‐value
Age	70.33 (13)	75.50 (12)	<.001*
Female	124 (60.8%)	36 (78.3%)	.028*
Marital status			.878
Single	28 (13.9%)	6 (13.3%)
Married	139 (69.2%)	30 (66.7%)
Divorced or widowed	34 (16.9%)	9 (20%)
Educational years			.097
Uneducated to 6 years	46 (27.4%)	18 (45%)
7‐12 years	33 (19.6%)	6 (15%)
More than 12 years	89 (53%)	16 (40%)
Family history of NCD	31 (78.5%)	8 (25.8%)	1
Only first‐degree relationship	20 (17.7%)	8 (25.8%)	.442
Substance (current or ever)
Alcohol use	21 (20.2%)	3 (11.5%)	.404
Smoking	19 (18.3%)	3 (11.5%)	.563
Concerned problem
Cognitive	187 (91.7%)	44 (95.7%)	.54
Non‐cognitive	59 (28.9%)	17 (37%)	.292
Underlying disease and comorbidities
Diabetes mellitus	56 (27.5%)	16 (34.8%)	.368
Hypertension	142 (69.6%)	33 (71.7%)	.86
Hyperlipidemia	150 (73.5%)	33 (71.7%)	.854
Cardiovascular risk group or stroke	43 (21.1%)	11 (23.9%)	.693
Parkinson disease	13 (6.4%)	1 (2.2%)	.477
Vitamin D deficiency	23 (11.3%)	12 (26.1%)	.012*
Psychiatric disorder
Underlying; depressive disorders	20 (9.8%)	3 (6.5%)	.777
Comorbid Depression	26 (12.7%)	5 (10.9%)	.811
Medication–AChEI	32 (15.7%)	12 (26.1%)	.131

Abbreviations: AChEI, acetylcholinesterase inhibitor; MCI, mild cognitive impairment; NCDs, Neurocognitive disorders.

^* P value < .05 is considered as statistically significant.